22 reports

  • 2.3 Acne Treatment
  • 2.3 Acne Treatment

Scope of the Report The report entitled “Global Acne Treatment Market: (2017-2021 Edition)”, provides analysis of the global acne treatment market and its products, with detailed analysis of market size and growth in terms of value. The report also provides in brief about the market split. The global acne treatment market can...

  • Acne Treatment
  • Dermatological Condition
  • World
  • Market Size
  • Foamix Ltd.
  • Other acne treatment
  • Products and services segmentation (2016)

About face: Growth will be constrained as consumers opt for prescription treatments Abstract Acne Treatment Manufacturing OTC The Acne Treatment Manufacturing OTC industry benefits from fairly stable demand for these products because acne-prone individuals consider them a necessary...

  • Acne Treatment
  • OTC
  • Pharmaceutical
  • United States
  • Demand

Global Market Study on Acne Treatment: Inflammatory Acne Segment Anticipated to Account for ## BPS Gain in Market Revenue Share During 2017 – 2025 ##.

  • Acne Treatment
  • OTC
  • Pharmaceutical
  • World
  • Market Size
  • Recommendations for Antibiotic Therapy in Acne Treatment
  • Mechanism of Action of Current Available Treatments

Acne vulgaris, also known simply as acne, is a common, chronic, inflammatory disease of the glands that produce sebum (sebaceous follicles). This disease results in the formation of inflamed elevations (papules, pustules, nodules, and cysts), comedones (blackheads and whiteheads), and scars on the skin. Acne is one of the most common...

  • Acne Treatment
  • Allergan plc
  • Foamix Ltd.
  • GlaxoSmithKline plc
  • Novartis AG
  • Recommendations for Antibiotic Therapy in Acne Treatment
  • Mechanism of Action of Current Available Treatments

Acne vulgaris, also known simply as acne, is a common, chronic, inflammatory disease of the glands that produce sebum (sebaceous follicles). This disease results in the formation of inflamed elevations (papules, pustules, nodules, and cysts), comedones (blackheads and whiteheads), and scars on the skin. Acne is one of the most common...

  • Acne Treatment
  • Allergan plc
  • Foamix Ltd.
  • GlaxoSmithKline plc
  • Novartis AG
  • Nadifloxacin Drugs for Acne Treatments
  • Tretinoin Drugs for Acne Treatments

Acne vulgaris, also known as acne, is a common, chronic, inflammatory disease of the glands that produce sebum (sebaceous follicles). This disease results in the formation of inflamed elevations (papules, pustules, nodules, and cysts), comedones (blackheads and whiteheads), and scars on the skin. Acne is one of the most common disorders...

  • Acne Treatment
  • India
  • Allergan plc
  • Cipla Ltd
  • Novartis AG
  • 1.4 TREATMENT
  • 3.2 THE US ACNE DRUGS REVENUE

Acne is defined as a chronic skin disorder in which the hair follicles become blocked and/or inflamed. There are several variants of acne and they range from mild to severe. The most common type of acne is acne vulgaris (vulgaris means common). Acne appears most often on the face, but can also be a nuisance on chest,...

  • Acne Treatment
  • North America
  • United States
  • World
  • Allergan plc
  • Official Title
  • Clinical Trial profile. 384 Trial Title

Acne And Related Disorders Global Clinical Trials Review, H1, 2017 Summary GlobalData’s clinical trial report, “Acne And Related Disorders Global Clinical Trials Review, H1, 2017" provides an overview of Acne And Related Disorders clinical trials scenario. This report provides top line data relating to the clinical...

  • Acne Treatment
  • Clinical Trial
  • Dermatological Condition
  • Pharmaceutical
  • World
  • Official Title
  • Clinical Trial profile. 419 Trial Title

Acne Vulgaris Global Clinical Trials Review, H1, 2017 Summary GlobalData’s clinical trial report, “Acne Vulgaris Global Clinical Trials Review, H1, 2017" provides an overview of Acne Vulgaris clinical trials scenario. This report provides top line data relating to the clinical trials on Acne Vulgaris. Report includes...

  • Acne Treatment
  • Clinical Trial
  • Pharmaceutical
  • World
  • Product Initiative
  • ACNE VULGARIS - PIPELINE BY HOVIONE FARMACIENCIA SA, H2 2017
  • ACNE VULGARIS - PIPELINE BY HELIX BIOMEDIX INC, H2 2017

The abstract is entitled " BPX-## Minocycline ## percent topical Gel for the Treatment of Acne Vulgaris".

  • Acne Treatment
  • Pharmaceutical
  • United States
  • Company
  • Product Initiative
  • Market size and forecast
  • Acne drugs: Key buying criteria

Global Acne Drugs Market 2016-2020 Covering: This market research report presents a detailed segmentation of the global acne drugs market by drug class (antibiotics, anti-inflammatory drugs, antimicrobial, combination medications, hormonal agents, oral retinoid, and topical retinoid), by route of administration (topical, and oral), and...

  • Acne Treatment
  • Dermatological Condition
  • Allergan plc
  • Galderma S.A.
  • Valeant Pharmaceuticals International, Inc.

Acne Phase ## Clinical Trials, 2016 ##.

  • Acne Treatment
  • Dermatological Condition
  • Japan
  • Demand
  • Market Shares

US Acne Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Acne Treatments ##) Acne Pipeline ##) US Acne Epidemiology ##) Marketed Drugs for Acne in US ##) US Acne M

  • Acne Treatment
  • Dermatological Condition
  • United States
  • Demand
  • Market Shares

Acne Phase ## Clinical Trials, 2016 ##.

  • Acne Treatment
  • Dermatological Condition
  • Germany
  • Demand
  • Market Shares

UK Acne Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Acne Treatments ##) Acne Pipeline ##) UK Acne Epidemiology ##) Marketed Drugs for Acne in UK ##) UK Acne M

  • Acne Treatment
  • Dermatological Condition
  • United Kingdom
  • Demand
  • Market Shares

Acne Phase ## Clinical Trials, 2016 ##.

  • Acne Treatment
  • Dermatological Condition
  • Italy
  • Demand
  • Market Shares

Acne Phase ## Clinical Trials, 2016 ##.

  • Acne Treatment
  • Dermatological Condition
  • France
  • Demand
  • Market Shares

Acne Phase ## Clinical Trials, 2016 ##.

  • Acne Treatment
  • Dermatological Condition
  • Spain
  • Demand
  • Market Shares
  • Clinical Trial profile. 408 Trial Title
  • Clinical Trial profile. 431 Trial Title

Acne Vulgaris Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Acne Vulgaris Global Clinical Trials Review, H2, 2016" provides an overview of Acne Vulgaris clinical trials scenario. This report provides top line data relating to the clinical trials on Acne Vulgaris. Report includes an...

  • Acne Treatment
  • Clinical Trial
  • Drug Discovery And Development
  • World
  • Product Initiative
  • TYPES AND SYMPTOMS OF DERMATITIS
  • 4.1 GLOBAL ACNE VULGARIS MARKET, 2016 - 2026

GMR Data forecasts that revenues for the dermatology drug market will reach $83.2bn in 2026. In this brand new, independently created, pharmaceutical report discover prospects for leading companies and products in the dermatology drugs market today.   5 Reasons why you must read this report today: 1. Dermatology drug...

  • Acne Treatment
  • World
  • Forecast
  • Allergan plc
  • Valeant Pharmaceuticals International, Inc.
  • Clinical Trial profile. 381 Trial Title
  • Clinical Trial profile. 391 Trial Title

Acne And Related Disorders Global Clinical Trials Review, H2, 2015 Summary GlobalData's clinical trial report, “Acne And Related Disorders Global Clinical Trials Review, H2, 2015" provides an overview of Acne And Related Disorders clinical trials scenario. This report provides top line data relating to the clinical trials...

  • Acne Treatment
  • Clinical Trial
  • Pharmaceutical
  • World
  • Product Initiative
  • ACNE VULGARIS - PIPELINE BY HOVIONE FARMACIENCIA SA,
  • ACNE VULGARIS - PIPELINE BY HELIX BIOMEDIX INC,

Diana Harbort, CEO of Cassiopea SpA, commented: " The antibiotic segment is one of the largest markets for the treatment of acne.

  • Acne Treatment
  • Pharmaceutical
  • United States
  • Company
  • Product Initiative